47
Views
0
CrossRef citations to date
0
Altmetric
Review

Mitral regurgitation: challenges and solutions

, &
Pages 61-67 | Published online: 03 May 2016

References

  • Cutler EC, Levine SA. Cardiotomy and Valvulotomy for Mitral Stenosis; Experimental Observations and Clinical Notes Concerning an Operated Case with Recovery. The Boston Medical and Surgical Journal. 1923;188(26):1023–1027.
  • Duran CG, Pomar JL, Revuelta JM, et al. Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg. 1980;79(3):326–337.
  • Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg. 1971;61(1):1–13.
  • Gaur P, Kaneko T, McGurk S, Rawn JD, Maloney A, Cohn LH. Mitral valve repair versus replacement in the elderly: Short-term and long-term outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(4):1400–1406.
  • Cohn LH, Adams DH, Couper GS, et al. Minimally Invasive Cardiac Valve Surgery Improves Patient Satisfaction While Reducing Costs of Cardiac Valve Replacement and Repair. Annals of Surgery. 1997;226(4):421–428.
  • Navia JL, Cosgrove DM. Minimally invasive mitral valve operations. The Annals of Thoracic Surgery. 1996;62(5):1542–1544.
  • Chitwood WR, Elbeery JR, Moran JF. Minimally invasive mitral valve repair using transthoracic aortic occlusion. The Annals of Thoracic Surgery. 1997;63(5):1477–1479.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521–e643.
  • Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–883.
  • Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 2009;119(6):797–804.
  • Madesis A, Tsakiridis K, Zarogoulidis P, et al. Review of mitral valve insufficiency: repair or replacement. Journal of thoracic disease. 2014;6 (Suppl 1):S39–S51.
  • Montant P, Chenot F, Robert A, et al. Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg. 2009;138(6):1339–1348.
  • Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113(18):2238–2244.
  • Enriquez-Sarano M, Sundt TM. Early Surgery Is Recommended for Mitral Regurgitation. Circulation. 2010;121(6):804–812.
  • Gillinov AM, Mihaljevic T, Blackstone EH, et al. Should Patients With Severe Degenerative Mitral Regurgitation Delay Surgery Until Symptoms Develop? The Annals of Thoracic Surgery. 2010;90(2):481–488.
  • Suri RM, Vanoverschelde JL, Grigioni F, et al. Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets. JAMA. 2013;310(6):609.
  • Adams DH, Anyanwu AC. Valve Disease: Asymptomatic mitral regurgitation: does surgery save lives? Nat Rev Cardiol. Vol 6. England 2009:330–332.
  • Detaint D, Iung B, Lepage L, et al. Management of asymptomatic patients with severe non-ischaemic mitral regurgitation. Are practices consistent with guidelines? Eur J Cardiothorac Surg. 2008;34(5):937–942.
  • Schaff HV. Asymptomatic severe mitral valve regurgitation: observation or operation? Circulation. Vol 119. United States 2009:768–769.
  • Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. The Annals of Thoracic Surgery. 2002;74(2):600–601.
  • Acker MA, Parides MK, Perrault LP, et al. Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. New England Journal of Medicine. 2014;370(1):23–32.
  • Smith PK, Puskas JD, Ascheim DD, et al. Surgical Treatment of Moderate Ischemic Mitral Regurgitation. New England Journal of Medicine. 2014;371(23):2178–2188.
  • Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scandinavian journal of immunology. 2007;66(2–3):199–207.
  • Ayoub EM. Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness. Postgraduate medicine. 1992;92(3):133–136, 139–142.
  • Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet. Infectious diseases. 2005;5(11):685–694.
  • Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470–476.
  • Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation. 2005;112(23):3584–3591.
  • Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation–Part I. Clinical cardiology. 1994;17(6):330–336.
  • Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation–Part II. Clinical cardiology. 1994;17(7):395–402.
  • Chen FY, Cohn LH. Chapter 41. Mitral Valve Repair. In: Cohn LH, ed. Cardiac Surgery in the Adult, 4e. New York, NY: The McGraw-Hill Companies; 2012.
  • Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis. 2005;14(2):251–256.
  • Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. The American journal of pathology. 2004;165(5):1583–1591.
  • Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–784.
  • DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly NE, Cohn LH. Four decades of experience with mitral valve repair: Analysis of differential indications, technical evolution, and long-term outcome. The Journal of Thoracic and Cardiovascular Surgery. 2010;139(1):76–84.
  • Butany J, Collins MJ, David TE. Ruptured synthetic expanded polytetrafluoroethylene chordae tendinae. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2004;13(3):182–184.
  • Farivar RS, Shernan SK, Cohn LH. Late rupture of polytetrafluoroethylene neochordae after mitral valve repair. J Thorac Cardiovasc Surg. 2009;137(2):504–506.
  • Rankin JS, Burrichter CA, Walton-Shirley MK, et al. Trends in mitral valve surgery: a single practice experience. J Heart Valve Dis. 2009;18(4):359–366.
  • Shahin GM, van der Heijden GJ, Kelder JC, Boulaksil M, Knaepen PJ, Six AJ. Long-term follow-up of mitral valve repair: a single-center experience. Medical science monitor : international medical journal of experimental and clinical research. 2006;12(7):Cr308–Cr314.
  • Zhang ZW, Gu TX, Xiu ZY. Management of mild aortic valve stenosis in rheumatic mitral surgery. J Thorac Cardiovasc Surg. 2014;148(6):3254–3255.
  • Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg. 2000;119(1):53–60.
  • Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–1754.
  • Dreyfus G, Serraf A, Jebara VA, et al. Valve repair in acute endocarditis. Ann Thorac Surg. 1990;49(5):706–711; discussion 712–703.
  • Mihaljevic T, Paul S, Leacche M, et al. Tailored surgical therapy for acute native mitral valve endocarditis. J Heart Valve Dis. 2004;13(2):210–216.
  • Ad N. Transient systolic anterior motion after mitral valve repair: does it affect long-term outcomes? J Thorac Cardiovasc Surg. 2015;149(2):477–478.
  • Brown ML, Abel MD, Click RL, et al. Systolic anterior motion after mitral valve repair: is surgical intervention necessary? J Thorac Cardiovasc Surg. 2007;133(1):136–143.
  • Maslow AD, Singh A. Mitral valve repair: to slide or not to slide-precardiopulmonary bypass echocardiogram examination. Journal of cardiothoracic and vascular anesthesia. 2006;20(6):842–846.
  • Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove DM. Mechanism of outflow tract obstruction causing failed mitral valve repair. Anterior displacement of leaflet coaptation. Circulation. 1993; 88(5 Pt 2):Ii24–Ii29.
  • Mihaileanu S, Marino JP, Chauvaud S, et al. Left ventricular outflow obstruction after mitral valve repair (Carpentier’s technique). Proposed mechanisms of disease. Circulation. 1988;78(3 Pt 2):I78–I84.
  • Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. The Annals of Thoracic Surgery. 2003;75(2):620–632.
  • Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA. Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. Journal of the American College of Cardiology. 1999;34(7):2096–2104.
  • Brinster DR, Unic D, D’Ambra MN, Nathan N, Cohn LH. Midterm Results of the Edge-to-Edge Technique for Complex Mitral Valve Repair. The Annals of Thoracic Surgery. 2006;81(5):1612–1617.
  • Crescenzi G, Landoni G, Zangrillo A, et al. Management and decision-making strategy for systolic anterior motion after mitral valve repair. J Thorac Cardiovasc Surg. 2009;137(2):320–325.
  • Ibrahim M, Rao C, Ashrafian H, Chaudhry U, Darzi A, Athanasiou T. Modern management of systolic anterior motion of the mitral valve. Eur J Cardiothorac Surg. 2012;41(6):1260–1270.
  • Loulmet DF, Yaffee DW, Ursomanno PA, et al. Systolic anterior motion of the mitral valve: a 30-year perspective. J Thorac Cardiovasc Surg. 2014;148(6):2787–2793.
  • Kuperstein R, Spiegelstein D, Rotem G, et al. Late clinical outcome of transient intraoperative systolic anterior motion post mitral valve repair. J Thorac Cardiovasc Surg. 2015;149(2):471–476.
  • Maisano F. The edge-to-edge technique: a simplified method to correct mitral insufficiency. European Journal of Cardio-Thoracic Surgery. 1998;13(3):240–246.
  • Myers PO, Khalpey Z, Maloney AM, Brinster DR, D’Ambra MN, Cohn LH. Edge-to-edge repair for prevention and treatment of mitral valve systolic anterior motion. The Journal of Thoracic and Cardiovascular Surgery. 2013;146(4):836–840.